Cite
APA Citation
Wang, M., Timmons, L., Koop, A., & Tremaine, W. (n.d.). s958 Pharmacogene CYP1A2*1F Polymorphism Lowers Anti-TNF (infliximab) Response in Inflammatory Bowel Disease Patients. American journal of gastroenterology, 116, S458. http://access.bl.uk/ark:/81055/vdc_100144523340.0x00004a